Technical Program | AIChE

91成人短视频

Technical Program

Technical Program for the 6th International Conference on CRISPR Technologies.

To View Abstract for CRISPR Conference please  


Start Time End Time  
October 17, 2023 All Eastern Standard Time
    Day 1
8:00 AM 4:00 PM Registration
9:00 AM 9:10 AM Welcome Remarks by Chairs: Kristin Knouse, MIT, Andrew Anzalone, Prime Medicine, & Benjamin Kleinstiver, Harvard
9:10 AM 10:00 AM KEYNOTE: Base editing and prime editing: correcting mutations that cause genetic disease in cells, animals, and patients, David Liu, Broad Institute
10:00 AM 10:30 AM Morning Coffee Break Sponsored by Synthego
10:30 AM 12:25 PM CRISPR Biology, Tools, and Applications; Session Chairs: Jonathan Strecker & Andrew Anzalone
10:30 AM 10:55 AM Invited Speaker: CRISPR-like RNAs regulate expression of cas genes, Sergey Shmakov, NIH
10:55 AM 11:20 AM Invited Speaker: Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering, Soumya Kannan, Broad Institute
11:20 AM 11:45 AM Invited Speaker: Precision genome editing with DNA-dependent DNA polymerases and exogenous DNA-containing templates, Erik Sontheimer, University of Massachusetts
11:45 AM 12:05 PM Selected Abstract: RNA-Guided Type V CRISPR Nucleases Are Small, Efficient Genome Editing Tools with Diverse Targeting Capabilities, Lisa M. Alexander, Metagenomi
12:05 PM 12:25 PM Selected Abstract: Dynamics and Mechanics of R-Loop Formation during DNA Interrogation By Cas12a from Different Species, Kevin Aris, Stanford University 
12:25 PM 1:25 PM Lunch 
1:25 PM 2:55 PM Epigenetic and RNA editing Session Chairs: Morgan Maeder & Kristin Knouse
1:25 PM 1:50 PM Invited Speaker: Unlocking OPERA Platform to Activate Transcription Factor, Venkat Krishnamurthy, Korro Bio
1:50 PM 2:15 PM Invited Speaker: Enhancing Genome and Transcriptome Engineering: New Approaches, New Challenges, Prashant Mali, UC San Diego
2:15 PM 2:35 PM Selected Abstract: Development of Cas12a for Multiplexed Genome-Scale Transcriptional Activation Yanjing Liu, The Broad Institute of MIT and Harvard
2:35 PM 2:55 PM Selected Abstract: Next-Generation Epigenome Editors As Tools for Basic Discovery and Therapeutic Intervention, Edwin Neumann, MIT, Whitehead Institute for Biomedical Research
2:55 PM 3:25 PM Afternoon Coffee Break 
3:25 PM 5:20 PM High-Throughput Functional Genomics Session Chairs: Kristin Knouse & Manda Arbab
3:25 PM 3:50 PM Invited Speaker: CRISPR-based decoding of disease-associated genomic variants, Richard Sherwood, Brigham and Women's Hospital
3:50 PM 4:15 PM Invited Speaker: Single-cell high-content screening via genomic perturbation profiling at scale, Paul Blainey, MIT and Broad Institute
4:15 PM 4:40 PM Invited Speaker: Karyocreate: A CRISPR-based technology to study chromosome-specific aneuploify by targeting human centromeres, Teresa Davoli, NYU
4:40 PM 5:00 PM Selected Abstract: Reprogramming Functional Transcription Factor Binding Sites in Regulatory DNA with Pooled Prime Editing, Michael Montgomery, Stanford University
5:00 PM 5:20 PM Selected Abstract: Mapping the Genetic Interaction Network of PARP Inhibitor Response, Jia Ling, Princeton University
5:20 PM 6:20 PM Poster Session 1 and Cocktail Reception Sponsored by Collaborative Center for X-linked Dystonia Parkinsonism
     
Start Time End Time  
October 18, 2023 All Eastern Standard Time
    Day 2
8:30 AM 4:00 PM Registration
9:00 AM 9:10 AM Welcome Remarks by Chair: Andrew Anzalone, Prime Medicine
9:10 AM 10:00 AM KEYNOTE: From reading the genome for risk to rewriting it for cardiovascular health, Sekar Kathiresan, Verve Therapeutics
10:00 AM 10:30 AM Morning Coffee Break
10:30 AM 12:25 PM Progress Towards The Clinic Session Chairs: Morgan Maeder & Manda Arbab
10:30 AM 10:55 AM Invited Speaker: Correcting Pathogenic Mutations via Prime Editing, Gerald Schwank, University of Zurich
10:55 AM 11:20 AM Invited Speaker: Base editing rescue of spinal muscular atrophy in cells and in mice, Mandana Arbab, Harvard Medical School
11:20 AM 11:45 AM Invited Speaker: Modularity of In Vivo CRISPR Therapies, Jonathan Phillips, Intellia Tx
11:45 AM 12:05 PM Selected Abstract: Gene Editing without Ex Vivo culture Evades Genotoxicity in Human Hematopoietic Stem Cells, Jing Zeng, Boston Children's Hospital
12:05 PM 12:25 PM Selected Abstract: Rapid, Definitive Treatment of Phenylketonuria in Variant-Humanized Mice with Corrective Editing, Dominique Brooks, University of Pennsylvania
12:25 PM 1:55 PM Lunch Workshop: Challenges for CNS Delivery Sponsored by Collaborative Center for X-linked Dystonia Parkinsonism; Session Chair: Mandana Arbab & Ben Kleinstiver
12:40 PM 12:55 PM Structure-activity relationships guided engineering of AAV capsids with optimized skeletal muscle, cardiac muscle, and CNS tropism, Charlie Albright, Affinia Therapeutics
12:55 PM 1:10 PM Invited Speaker: Targeted Gene Regulation in the CNS Using Engineered Zinc Finger Protein Transcription Factors, Andrew Young, Sangamo Therapeutics
1:10 PM 1:25 PM Invited Speaker: Teaching old AAVs new tricks: enhancing CNS gene delivery by engineering capsid-receptor interactions, Ben Deverman, Broad Institute of MIT
1:25 PM 1:50 PM Round Table Panel Discussion led by Mandans & Ben; Panelists: Charlie Albright, Affinia Therapeutics, Andrew Young, Sangamo Therapeutics, Ben Deverman, Broad Institute of MIT, Samagya Banskota, Boston University
1:55 PM 3:30 PM Advances In Delivery Session Chairs: Matt Stanton & Kristin Knouse
1:55 PM 2:20 PM Invited Speaker: Efficient prime editing in mouse brain, liver and heart with dual AAVs, Samagya Banskota, Boston University
2:20 PM 2:45 PM Invited Speaker: Addressing key challenges for non-viral DNA delivery, Matt Stanton, Generation Bio
2:45 PM 3:10 PM Invited Speaker: Targeted LNP-RNA: an evolving modality for gene editing, Hamideh Parhiz, UPenn
3:10 PM 3:30 PM Selected Abstract: Quantifying how dozens of LNPs deliver mRNA in vivo with single-cell resolution using multiomics, Hyejin Kim, Georgia Institute of Technology/Emory University
3:30 PM 4:00 PM Afternoon Coffee Break Sponsored by Synthego
4:00 PM 5:55 PM Therapeutic Considerations Session Chairs: Jeffrey Quinn & Ben Kleinstiver
4:00 PM 4:25 PM Invited Speaker: Human genetic diversity alters off-target outcomes of therapeutic gene editing, Luca Pinello, MGH
4:25 PM 4:50 PM Invited Speaker: Defining and understanding the genome-wide off-target activity of CRISPR genome editors, Cicera Lazzarotto, Beam Therapeutics 
4:50 PM 5:10 PM Selected Abstract: Base Editing As a Genetic Treatment for Spinal Muscular Atrophy, Christiano Alves, MGH
5:10 PM 5:30 PM Selected Abstract: Modulating Nucleotide Metabolism Enhances Prime Editing in Hematopoietic Stem and Progenitor Cells, Sebastien Levesque, Boston Children's Hospital
5:30 PM 5:55 PM Invited Speaker: Why in vivo somatic editing must be a priority for low- and middle-income countries, Kiran Musunuru, UPenn
     
October 19, 2023 All Eastern Standard Time
    Day 3
8:30 AM 4:00 PM Registration
9:00 AM 9:10 AM Welcome Remarks by Chair: Benjamin Kleinstiver, Harvard
9:10 AM 10:00 AM KEYNOTE: A Platform Approach to Develop and Deploy CRISPR-Cas Based Experimental Therapies for Inborn Errors of Immunity in an Academic/Nonprofit Setting, Fyodor Urnov, IGI
10:00 AM 10:30 AM Morning Coffee Break
10:30 AM 12:25 PM Structural Biology and Synthetic Biology Session Chairs: Jonathan Strecker & Ben Kleinstiver
10:30 AM 10:55 AM Invited Speaker: Mechanism of RNA-guided and RNA-independent DNA integration by type V-K CRISPR-associated transposons, Jung-un Park, Cornell University
10:55 AM 11:20 AM Invited Speaker: Next-generation continuous evolution technologies to create custom biomolecules, Ahmad Khalil, Boston University
11:20 AM 11:45 AM Invited Speaker: RNA-guided DNA cleavage mechanism by IscB鈥愊塕NA, and efforts to improve its genome editing efficiency, Ailong Ke, Cornell University
11:45 AM 12:05 PM Selected Abstract: Engineering Activatable Promoters for Deep, Wide, and Conditional CRISPRa/i Circuits, Diego Alba Burbano, University of Washington 
12:05 PM 12:25 PM Selected Abstract: Development of Compact Transcriptional Effectors Using High-Throughput Measurements in Diverse Contexts, Josh Tycko, Harvard Medical School
12:25 PM 1:25 PM Lunch 
1:25 PM 2:55 PM Genome Editing Technologies for Small Sequence Edits Session Chairs: Jeffrey Quinn & Andrew Anzalone
1:25 PM 1:50 PM Invited Speaker: Engineered CRISPR Technologies to Improve Genome Editing, Benjamin Kleinstiver, Harvard University
1:50 PM 2:15 PM Invited Speaker: Andrew Anzalone, Prime Medicine
2:15 PM 2:35 PM Selected Abstract: Click-to-Install Genome Editing Using RNA-Programmable DNA-Dependent Polymerases and HUH Endonucleases, Joana Ferreira da Silva, MGH/Harvard, Connor Tou, MGH/MIT
2:35 PM 2:55 PM Selected Abstract: DNA Cryptography in Living Cells through Multi-Site Base Editing, Verena Volf, Harvard Medical School
2:55 PM 3:25 PM Afternoon Coffee Break
3:25 PM 5:20 PM Genome Editing Technologies for Large Sequence Edits Session Chairs: Andrew Anzalone & Ben Kleinstiver
3:25 PM 3:50 PM Invited Speaker: Programmable molecular technologies for genome editing and cell control, Omar Abudayyeh, MIT & Jonathan Gootenberg, MIT
3:50 PM 4:15 PM Invited Speaker: Structure and engineering of LINE retrotransposons, Max Wilkinson, MIT
4:15 PM 4:40 PM Invited Speaker: Molecular requirements for CRISPR RNA-guided transposition, Matt Walker, Columbia University
4:40 PM 5:00 PM Selected Abstract: Programmable Multi-Kilobase RNA Editing Using CRISPR-Mediated Trans-Splicing, Basem Al-Shayeb, Amber Bio, Inc.
5:00 PM 5:20 PM Selected Abstract: Phage-Assisted Evolution and Protein Engineering Yield Compact, Efficient Prime Editors, Smriti Pandey, Harvard University/ The Broad Institute
5:20 PM 5:35 PM Closing Remarks by Chairs: Kristin Knouse, MIT, Andrew Anzalone, Prime Medicine,  & Benjamin Kleinstiver, Harvard